A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 505 participants.
Also called NCT02444338
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 505 participants
- Sponsor
- University Medical Center Goettingen
- Registry
-
NCT02444338
-
- Other papers using this trial's data
- Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia, Denmark, Germany, Greece, Italy, Poland, Portugal, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02444338. Randomized; single masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2024-04-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation
- Acronym
- Reshape-HF2
- Condition
- Mitral Valve Insufficiency
- Intervention (Device)
- MitraClip
- Intervention (Other)
- standard of care
- Lead sponsor
- University Medical Center Goettingen
Record details
- Record id
cardio:ct-nct02444338- Content hash
f46c105218e283cf5df58ddf4d6a167839847dbf72c6292277de9af838b75f59